MRI Safe Implantable Device Market: Future Scope and Current Growth 2016 - 2024

Changing in the life style of population leads to various types of degenerative and chronic disease that affects the biological structure. In support to biological structure, various types of devices are implanted in human body that helps in replacing and enhancing the biological structure. These medical implants are man-made devices that are introduced in human body through surgical procedures and are left in the body after treatment. These devices are mostly implanted in geriatric population suffering from organ degeneration. During Magnetic Resonance Imaging (MRI) procedure some implant devices may fail to provide necessary treatment and compromise on patient safety which can lead to severe harm or death of the patient. To overcome this problem, many companies are trying to develop various type of implantable devices with non-ferromagnetic materials that overcome the harmful effect of MRI on patient.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/11083


Global MRI safe implantable device market is witnessing high growth owing to shifting lifestyle choices, high incidence of degenerative and chronic disease, rising geriatric population and technology advancement in implantable devices such as high-field MRI, software applications, superconducting magnets and open architecture. However, high cost of MRI safe implantable devices and inadequate reimbursement policies for MRI safe implantable devices may hamper the growth of MRI safe implantable device market over the forecast period.

Most of the orthopedic implants are made from non-ferromagnetic materials and helps in an escalating the number of patients for MRI procedure. On the other hand, in some orthopedic implants instances owing to formation of conductive loop there might be some MRI related heating problem. Due to widespread use of vascular access and catheters most of the patients may require MRI procedures which in turn exhibits the growth of global MRI safe implantable device market.

Depending on geographic region, global MRI safe implantable device market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America held the largest revenue share in the global MRI safe implantable device market followed by Europe and Asia Pacific owing to increase in geriatric population, technological advancements, increasing awareness for safe procedures and increase in the healthcare expenditure per capita. The developing nations in Asia Pacific, Middle East and Africa hold huge potential for growth in the global MRI safe implantable device market due to increase in chronic degenerative diseases along with healthcare expenditure.

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/11083

Some of the key participating global players in global MRI safe implantable device market are Medtronic plc, Zimmer Holdings Inc., Abbott Laboratories, Cochlear Ltd., Biotronik, Boston Scientific Corporation, St. Jude Medical Inc, Smiths Medical, AbbVie, Inc., TriVascular2, Inc. Stryker Corporation, Smith And Nephew Plc, and Johnson & Johnson.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

Telephone - +1-646-568-7751

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.